Search CROs

• Analytical Method Development & Validation
• Bioanalysis
• Biomarker Assays

Global CRDMO partner offering integrated discovery-to-commercialization services across small molecules and biologics, with 4000+ scientists and R&D/manufacturing campuses in Asia, North America, and Europe.

• Analytical Method Development & Validation
• Bioanalysis
• Biomarker Assays

Integrated CRDMO with 30 years of expertise spanning discovery chemistry, biology, DMPK, and IND-enabling development for small and large molecules, plus API and drug product manufacturing.

• Analytical Method Development & Validation
• Bioanalysis
• Bioinformatics & Data Science

Premier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK.

• Analytical Method Development & Validation
• Bioanalysis
• Biomarker Assays

Global CRDMO platform providing integrated end-to-end contract research, development, and manufacturing services across discovery, preclinical, clinical, and commercial phases for small molecules, peptides, oligonucleotides, and biologics across 30+ countries.

• Bioanalysis
• Biomarker Assays
• Biostatistics & Statistical Programming

Full-service CRO with 30+ years of organic growth, offering integrated clinical development services across all phases with wholly-owned central labs, bioanalytical lab, imaging core lab, and Phase I unit.

• Bioanalysis
• Biomarker Assays
• Biostatistics & Statistical Programming

PPD is a leading global contract research organization (CRO) and the clinical research business of Thermo Fisher Scientific. The organization provides comprehensive drug development, laboratory, and lifecycle services to pharmaceutical, biotechnology, medical device,…

• Bioanalysis
• Biostatistics & Statistical Programming
• Cardiovascular & Metabolic Specialty Services

Global CRO with 26,000+ employees offering integrated clinical development, regulatory affairs, and commercialization services. Helped develop or commercialize 96% of FDA-approved oncology drugs and 93% of EMA-authorized oncology products in the last five years.

• Biomarker Assays
• Biostatistics & Statistical Programming
• Clinical Operations

Parexel is a comprehensive CRO offering end-to-end biopharmaceutical development services spanning portfolio optimization, early development, integrated clinical development, regulatory approval, and lifecycle value substantiation. The organization delivers Phase I–IV…

• Biostatistics & Statistical Programming
• Central Laboratory Services
• Clinical Imaging Core Lab

Fortrea is a leading CRO advancing clinical trials through patient-focused clinical solutions that accelerate clinical development and drive trial success.

• Bioanalysis
• Biomarker Assays
• Biostatistics & Statistical Programming

Labcorp Early Development Services is part of Labcorp, a global life sciences and healthcare company offering integrated drug development and diagnostic services. The organization supports nonclinical research, central laboratory services, early phase development, regulatory…

• Bioanalysis
• Biomarker Assays
• Biostatistics & Statistical Programming

ICON is a world-leading clinical research organization providing outsourced services across the full clinical trial lifecycle, from early phase through commercialization, to pharmaceutical, biotechnology, and medical device companies.

• Bioanalysis
• Bioinformatics & Data Science
• Biomarker Assays

IQVIA is a global life sciences and healthcare company providing data, expertise, AI, analytics, and technology solutions to support clinical development and improve patient outcomes.

• Clinical Operations
• Phase I Clinical Trials
• Phase II Clinical Trials

Global mid-size CRO specializing in dermatology, internal medicine, neuroscience, oncology, and ophthalmology with Phase I-IV clinical development, real-world evidence studies, and flexible resourcing solutions across 600+ experts in Europe, North America, and Australia.

• Biostatistics & Statistical Programming
• Cardiovascular & Metabolic Specialty Services
• Clinical Operations

Full-service CRO specializing in Phase I–IV clinical trials across oncology, cardiovascular, metabolic, CNS, dermatological, infectious, and respiratory diseases, with global trial management capabilities and expertise in rare tumor research.

• Clinical Trial Services
• GLP Toxicology
• Preclinical In Vitro Studies

Esco Aster is a vertically integrated CDMO and CRO delivering end-to-end contract solutions from process development and GMP manufacturing through clinical research, with specialized capabilities in vaccine production, cell therapy, plasmid DNA, extracellular vesicles, and GLP toxicology.

• Immunology & Inflammation Services
• In Vitro Pharmacology
• In Vivo Efficacy Models

Cyagen provides genetically engineered animal models, custom cell lines, and viral packaging services for preclinical drug discovery, with specialized platforms including HUGO-GT™ and HUGO-Ab™ for humanized target validation and antibody screening.

• Discovery Research
• In Vivo Efficacy Models
• Preclinical In Vitro Studies

Cyagen provides genetically engineered animal models, custom cell lines, and viral packaging services for preclinical research, with specialized expertise in humanized mice, gene therapy vectors, and disease-specific models across oncology, neurology, and metabolic disorders.

• Clinical Operations
• Regulatory Affairs
• US FDA Regulatory Strategy

Critical Path Institute convenes pharmaceutical, government, patient, and academic organizations to optimize drug and medical product development through collaborative consortia, regulatory science initiatives, and clinical trial design optimization.